CervoMed
Price & Volume
Stats
See more52W Range | $2.13-$10 |
Market Cap | $48.6M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $331,295 |
Revenue Growth (YoY) | -99.6% |
Gross Profit (12 Mos) | -$20.9M |
Diluted EPS | -$3.21 |
News
See moreYahoo Finance • 3 months ago
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
Yahoo Finance • 3 months ago
CervoMed Completes Enrollment In Phase 2a Study Of Neflamapimod For Nfv.Primary Progressive Aphasia
About
CEO | Dr. John J. Alam M.D. |
CFO | Mr. William Robert Elder J.D. |
Address | 20 Park Plaza, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |